Literature DB >> 33244611

A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort.

Xiaodong Niu1, Yuan Yang1, Xingwang Zhou1, Haodongfang Zhang1, Yuekang Zhang1, Yanhui Liu1, Qing Mao1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33244611      PMCID： PMC7906053          DOI： 10.1093/neuonc/noaa268

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.

Authors:  Erica Shen; Margaret O Johnson; Jessica W Lee; Eric S Lipp; Dina M Randazzo; Annick Desjardins; Roger E McLendon; Henry S Friedman; David M Ashley; John P Kirkpatrick; Katherine B Peters; Kyle M Walsh
Journal:  Neurooncol Adv       Date:  2019-12-20

2.  Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients.

Authors:  Wen Cheng; Chuanbao Zhang; Xiufang Ren; Zheng Wang; Xing Liu; Sheng Han; Anhua Wu
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

3.  An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Authors:  Haley Gittleman; Daniel Lim; Michael W Kattan; Arnab Chakravarti; Mark R Gilbert; Andrew B Lassman; Simon S Lo; Mitchell Machtay; Andrew E Sloan; Erik P Sulman; Devin Tian; Michael A Vogelbaum; Tony J C Wang; Marta Penas-Prado; Emad Youssef; Deborah T Blumenthal; Peixin Zhang; Minesh P Mehta; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

4.  Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years.

Authors:  Xiaodong Niu; Tianwei Wang; Xingwang Zhou; Yuan Yang; Xiang Wang; Haodongfang Zhang; Ni Chen; Qiang Yue; Feng Wang; Yuekang Zhang; Yanhui Liu; Qing Mao
Journal:  J Neurooncol       Date:  2020-03-10       Impact factor: 4.130

5.  An independently validated survival nomogram for lower-grade glioma.

Authors:  Haley Gittleman; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

6.  A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort.

Authors:  Ming-Zhi Han; Bin Huang; Shi-Lei Ni; Jian Wang; Xin-Gang Li; Rolf Bjerkvig
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

7.  An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.

Authors:  Haley Gittleman; Gino Cioffi; Pranathi Chunduru; Annette M Molinaro; Mitchel S Berger; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Neurooncol Adv       Date:  2019-05-30
  7 in total
  1 in total

1.  A Novel Nomogram for Predicting the Risk of Short-Term Recurrence After Surgery in Glioma Patients.

Authors:  Tianwei Wang; Chihao Zhu; Shuyu Zheng; Zhijun Liao; Binghong Chen; Keman Liao; Xi Yang; Zhiyi Zhou; Yongrui Bai; Zhenwei Wang; Yanli Hou; Yongming Qiu; Renhua Huang
Journal:  Front Oncol       Date:  2021-10-26       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.